한빛사 논문
Jing Li, PhD*, Kyungho Kim, PhD*, Si-Yeon Jeong, PhD, Joyce Chiu, PhD, Bei Xiong, MD, Pavel A. Petukhov, PhD, Xiangrong Dai, PhD Xiaoyi Li, PhD, Robert K. Andrews, PhD, Xiaoping Du, MD, PhD, Philip J. Hogg, PhD, Jaehyung Cho, PhD
Affiliations
Department of Pharmacology, University of Illinois College of Medicine, Chicago (J.L., K.K., S.-Y.J, B.X., X. Du, J. Cho). Korean Medicine-Application Center, Korea Institute of Oriental Medicine, Daegu (K.K.). The Centenary Institute, Newtown, NSW, Australia (J. Chiu, P.J.H.). National Health and Medical Research
Council Clinical Trials Centre, University of Sydney, NSW, Australia (J.Chiu, P.J.H.). Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, Chicago (P.A.P.). Lee’s Pharmaceutical Holdings Ltd, Shatin, Hong Kong (X. Dai, X.L.). Australian Centre for Blood Diseases, Monash University, Melbourne, VIC (R.K.A.).
*Drs J. Li and Kim contributed equally.
Correspondence : Jaehyung Cho, PhD.
Abstract
Background:
Platelet-neutrophil interactions contribute to vascular occlusion and tissue damage in thromboinflammatory disease. Platelet glycoprotein Ibα (GPIbα), a key receptor for the cell-cell interaction, is believed to be constitutively active for ligand binding. Here, we established the role of platelet-derived protein disulfide isomerase (PDI) in reducing the allosteric disulfide bonds in GPIbα and enhancing the ligand-binding activity under thromboinflammatory conditions.
Methods:
Bioinformatic analysis identified 2 potential allosteric disulfide bonds in GPIbα. Agglutination assays, flow cytometry, surface plasmon resonance analysis, a protein-protein docking model, proximity ligation assays, and mass spectrometry were used to demonstrate a direct interaction between PDI and GPIbα and to determine a role for PDI in regulating GPIbα function and platelet-neutrophil interactions. Also, real-time microscopy and animal disease models were used to study the pathophysiological role of PDI-GPIbα signaling under thromboinflammatory conditions.
Results:
Deletion or inhibition of platelet PDI significantly reduced GPIbα-mediated platelet agglutination. Studies using PDI-null platelets and recombinant PDI or Anfibatide, a clinical-stage GPIbα inhibitor, revealed that the oxidoreductase activity of platelet surface–bound PDI was required for the ligand-binding function of GPIbα. PDI directly bound to the extracellular domain of GPIbα on the platelet surface and reduced the Cys4-Cys17 and Cys209-Cys248 disulfide bonds. Real-time microscopy with platelet-specific PDI conditional knockout and sickle cell disease mice demonstrated that PDI-regulated GPIbα function was essential for platelet-neutrophil interactions and vascular occlusion under thromboinflammatory conditions. Studies using a mouse model of ischemia/reperfusion–induced stroke indicated that PDI-GPIbα signaling played a crucial role in tissue damage.
Conclusions:
Our results demonstrate that PDI-facilitated cleavage of the allosteric disulfide bonds tightly regulates GPIbα function, promoting platelet-neutrophil interactions, vascular occlusion, and tissue damage under thromboinflammatory conditions.
Key Words : blood platelets, glycoprotein Ibalpha, inflammation, neutrophils, protein disulfide, isomerase
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기